Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 01 Sept 2026 for Encompass Health Corp, €543k. Read the official filing
Filing timeline
BuySaleAndrew L. Price
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Andrew L. Price: trading record in brief
This profile gathers the share dealings of Andrew L. Price in Encompass Health Corp, where the filings describe the role as senior executive. Over a trading history stretching from 4 January 2016 to 31 August 2026, the count stands at 23 filings.
The open-market record consists of 2 sales worth €1.0M, with no purchase. Besides market trades, the filings include 20 share grants and 1 option exercise. Since January 2026: no purchases and 1 sale on the market.
On 1 September 2026 came the latest disclosure, an open-market sale for €543k in Encompass Health Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Andrew L. Price
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
5,211 shares@ US$120.930.0053% mcap26.2% of flowEncompass Health Common StockSEC:0000785161-26-000209:0
307 shares@ US$107.881.8% of flowEncompass Health Common StockSEC:0000785161-26-000095:0
404 shares@ US$106.152.4% of flowEncompass Health Common StockSEC:0000785161-26-000069:0
3,692 shares@ US$107.1521.9% of flowEncompass Health Common StockSEC:0000785161-26-000057:0
8,178 shares0Encompass Health Common StockSEC:0000785161-26-000041:0
304 shares@ US$100.142.5% of flowEncompass Health Common StockSEC:0001127602-25-007386:0
401 shares@ US$97.533.1% of flowEncompass Health Common StockSEC:0001127602-25-006827:0
1,538 shares0Encompass Health Common StockSEC:0001127602-25-006190:0
5,042 shares@ US$98.2940.1% of flowEncompass Health Common StockSEC:0001127602-25-004672:0
2,446 shares@ US$92.3518.3% of flowEncompass Health Common StockSEC:0001127602-25-000287:0
5,329 shares0Encompass Health Common StockSEC:0001127602-24-007570:0
400 shares@ US$75.252.3% of flowEncompass Health Common StockSEC:0001127602-24-006836:0
2,062 shares@ US$66.7210.5% of flowEncompass Health Common StockSEC:0001127602-24-000351:0
320 shares@ US$60.221.5% of flowEncompass Health Common StockSEC:0001127602-23-007408:0
4,388 shares0Encompass Health Common StockSEC:0001127602-23-006965:0
298 shares@ US$62.861.5% of flowEncompass Health Common StockSEC:0001127602-23-006535:0
1,344 shares@ US$59.816.3% of flowEncompass Health Common StockSEC:0001127602-23-000503:0
265 shares@ US$65.521.0% of flowEncompass Health Common StockSEC:0001127602-22-006969:0
525 shares@ US$65.912.0% of flowEncompass Health Common StockSEC:0001127602-22-006352:0
1,031 shares@ US$65.263.9% of flowEncompass Health Common StockSEC:0001127602-22-000854:0
9,000 sharesHealthsouth Common StockSEC:0001127602-16-039250:0
7,748 sharesHealthsouth Common StockSEC:0001127602-16-039250:1
3,449 sharesHealthsouth Common StockSEC:0001127602-16-036197:0
23 of 23 declarations
